| __timestamp | BioCryst Pharmaceuticals, Inc. | Xenon Pharmaceuticals Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 7461000 | 5496000 |
| Thursday, January 1, 2015 | 13047000 | 9786000 |
| Friday, January 1, 2016 | 11253000 | 6792000 |
| Sunday, January 1, 2017 | 13933000 | 7313000 |
| Monday, January 1, 2018 | 29514000 | 8382000 |
| Tuesday, January 1, 2019 | 37121000 | 10803000 |
| Wednesday, January 1, 2020 | 67929000 | 12944000 |
| Friday, January 1, 2021 | 118818000 | 21967000 |
| Saturday, January 1, 2022 | 159371000 | 32810000 |
| Sunday, January 1, 2023 | 213894000 | 46542000 |
Unleashing the power of data
In the competitive world of biopharmaceuticals, managing Selling, General, and Administrative (SG&A) expenses is crucial for financial health. Over the past decade, BioCryst Pharmaceuticals, Inc. and Xenon Pharmaceuticals Inc. have shown contrasting trends in their SG&A expenditures. From 2014 to 2023, BioCryst's SG&A expenses surged by nearly 2,800%, peaking at approximately $214 million in 2023. This reflects their aggressive expansion and investment in administrative capabilities. In contrast, Xenon Pharmaceuticals Inc. maintained a more conservative growth, with SG&A expenses increasing by around 750% to $46 million in the same period. This strategic restraint may indicate a focus on lean operations and targeted investments. Understanding these trends provides valuable insights into each company's strategic priorities and operational efficiencies, offering a glimpse into their future trajectories in the biopharma landscape.
Novo Nordisk A/S vs Xenon Pharmaceuticals Inc.: SG&A Expense Trends
SG&A Efficiency Analysis: Comparing Novartis AG and Xenon Pharmaceuticals Inc.
Comparing SG&A Expenses: Vertex Pharmaceuticals Incorporated vs Xenon Pharmaceuticals Inc. Trends and Insights
Operational Costs Compared: SG&A Analysis of Biogen Inc. and Xenon Pharmaceuticals Inc.
Comparing SG&A Expenses: United Therapeutics Corporation vs BioCryst Pharmaceuticals, Inc. Trends and Insights
Incyte Corporation or Xenon Pharmaceuticals Inc.: Who Manages SG&A Costs Better?
Breaking Down SG&A Expenses: Incyte Corporation vs BioCryst Pharmaceuticals, Inc.
Bio-Techne Corporation or Xenon Pharmaceuticals Inc.: Who Manages SG&A Costs Better?
Breaking Down SG&A Expenses: Xenon Pharmaceuticals Inc. vs ImmunityBio, Inc.
Breaking Down SG&A Expenses: Xenon Pharmaceuticals Inc. vs Geron Corporation
Ligand Pharmaceuticals Incorporated or BioCryst Pharmaceuticals, Inc.: Who Manages SG&A Costs Better?
Breaking Down SG&A Expenses: Amphastar Pharmaceuticals, Inc. vs BioCryst Pharmaceuticals, Inc.